Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hetrombopag for Selinexor-Induced Thrombocytopenia in Lymphoma
NCT05969158Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Sep 2023
- Primary completion
- May 2025
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of hetrombopag in chemotherapy-induced thrombocytopenia (CIT), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
hetrombopag
03
Conditions
chemotherapy-induced thrombocytopenia (CIT)
Beyond the preview
Go deeper on NCT05969158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05969158.